- Home
- PMCB vs CREV Comparison
PMCB vs CREV Comparison
Compare PMCB & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- CREV
- Stock Information
- Founded
- PMCB 1996
- CREV 2007
- Country
- PMCB United States
- CREV Ireland
- Employees
- PMCB N/A
- CREV N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- CREV
- Sector
- PMCB Health Care
- CREV
- Exchange
- PMCB Nasdaq
- CREV Nasdaq
- Market Cap
- PMCB 5.8M
- CREV 6.0M
- IPO Year
- PMCB N/A
- CREV N/A
- Fundamental
- Price
- PMCB $0.90
- CREV $4.61
- Analyst Decision
- PMCB
- CREV
- Analyst Count
- PMCB 0
- CREV 0
- Target Price
- PMCB N/A
- CREV N/A
- AVG Volume (30 Days)
- PMCB 38.8K
- CREV 445.0K
- Earning Date
- PMCB 08-11-2025
- CREV 05-14-2025
- Dividend Yield
- PMCB N/A
- CREV N/A
- EPS Growth
- PMCB N/A
- CREV N/A
- EPS
- PMCB 3.19
- CREV N/A
- Revenue
- PMCB N/A
- CREV $39,261,077.00
- Revenue This Year
- PMCB N/A
- CREV $40.76
- Revenue Next Year
- PMCB N/A
- CREV $86.18
- P/E Ratio
- PMCB $0.28
- CREV N/A
- Revenue Growth
- PMCB N/A
- CREV 41.52
- 52 Week Low
- PMCB $0.80
- CREV $2.00
- 52 Week High
- PMCB $2.42
- CREV $12.75
- Technical
- Relative Strength Index (RSI)
- PMCB 41.85
- CREV 53.68
- Support Level
- PMCB $0.84
- CREV $4.45
- Resistance Level
- PMCB $0.95
- CREV $4.96
- Average True Range (ATR)
- PMCB 0.07
- CREV 0.68
- MACD
- PMCB -0.00
- CREV -0.01
- Stochastic Oscillator
- PMCB 39.96
- CREV 53.21
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.